Your browser doesn't support javascript.
loading
Convergence of multiple RNA-silencing pathways on GW182/TNRC6.
Welte, Thomas; Goulois, Alison; Stadler, Michael B; Hess, Daniel; Soneson, Charlotte; Neagu, Anca; Azzi, Chiara; Wisser, Marlena J; Seebacher, Jan; Schmidt, Isabel; Estoppey, David; Nigsch, Florian; Reece-Hoyes, John; Hoepfner, Dominic; Großhans, Helge.
Affiliation
  • Welte T; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; Department of Medicine IV, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: thomas.welte@fmi.ch.
  • Goulois A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Stadler MB; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; SIB Swiss Institute of Bioinformatics, Basel, Switzerland; Faculty of Natural Sciences, University of Basel, Basel, Switzerland.
  • Hess D; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Soneson C; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; SIB Swiss Institute of Bioinformatics, Basel, Switzerland.
  • Neagu A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Azzi C; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Wisser MJ; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; Faculty of Natural Sciences, University of Basel, Basel, Switzerland.
  • Seebacher J; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Schmidt I; Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.
  • Estoppey D; Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.
  • Nigsch F; Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.
  • Reece-Hoyes J; Department of Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Hoepfner D; Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.
  • Großhans H; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; Faculty of Natural Sciences, University of Basel, Basel, Switzerland. Electronic address: helge.grosshans@fmi.ch.
Mol Cell ; 83(14): 2478-2492.e8, 2023 07 20.
Article in En | MEDLINE | ID: mdl-37369201
ABSTRACT
The RNA-binding protein TRIM71/LIN-41 is a phylogenetically conserved developmental regulator that functions in mammalian stem cell reprogramming, brain development, and cancer. TRIM71 recognizes target mRNAs through hairpin motifs and silences them through molecular mechanisms that await identification. Here, we uncover that TRIM71 represses its targets through RNA-supported interaction with TNRC6/GW182, a core component of the miRNA-induced silencing complex (miRISC). We demonstrate that AGO2, TRIM71, and UPF1 each recruit TNRC6 to specific sets of transcripts to silence them. As cellular TNRC6 levels are limiting, competition occurs among the silencing pathways, such that the loss of AGO proteins or of AGO binding to TNRC6 enhances the activities of the other pathways. We conclude that a miRNA-like silencing activity is shared among different mRNA silencing pathways and that the use of TNRC6 as a central hub provides a means to integrate their activities.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Argonaute Proteins Limits: Animals Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Argonaute Proteins Limits: Animals Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article